View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB09 Publication ID: Fall 2008 
Title: Registration List Requirements for Importers and Manufactures of Prescription Drug Products Containing Ephedrine, Pseudoephedrine, or Phenylpropanolamine 
Abstract: This rule supports those rules implementing the Combat Methamphetamine Epidemic Act of 2005 (title VII, Pub. L. 109-177) by ensuring that every location that manufactures the List I chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, or a drug product containing ephedrine, pseudoephedrine, or phenylpropanolamine, is registered with the DEA to conduct this activity. 
Agency: Department of Justice(DOJ)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1309   
Legal Authority: 21 USC 821 to 824    21 USC 830    21 USC 871(b)    21 USC 875    21 USC 877    21 USC 958   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  01/18/2008  73 FR 3432   
NPRM Comment Period End  03/18/2008    
Final Action  06/00/2009    
Additional Information: Docket DEA-294
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
Public Comment URL: www.regulations.gov  
RIN Data Printed in the FR: No 
Related RINs: Related to 1117-AB08 
Agency Contact:
Mark W. Caverly
Chief, Liaison and Policy Section
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:202 307-7297
Email: dea.diversion.policy@usdoj.gov